GAMIDA, the leader in France in the Intraperitoneal hyperthermia field, announced today a new strategic plan that will consolidate its market position and increase long-term profitability. To implement this plan, effective immediately the Company has taken action to streamline its operations by means of leadership and board changes and by bringing in new investors.
All of these steps will ensure and reinforce Gamida’s commitment to our employees, distributors, and investors and will counteract the baseless, negative rumors in the market.
We would take this opportunity to thank our customers worldwide for their ongoing support. We commit to continue to work closely with them to sell and service our existing product line and GamidaTech will continue to develop new products to meet the needs of the market. Our goal is not only to be the leader in Intraperitoneal hyperthermia technology in France, but also internationally.
If you have any queries, do not hesitate to contact
+33 139 598 600 / firstname.lastname@example.org
You can download the text here.
Gamida France, Corporate Communications
Please address further enquiries to email@example.com